GO:0032690 negative regulation of interleukin-1 alpha production: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032690 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha (IL-1α) production, including its biosynthesis and secretion.
• IL-1α is a dual-function cytokine that acts both as a nuclear alarmin and as a secreted inflammatory mediator, so its negative regulation is critical for preventing excessive inflammation.
• Key negative regulators include Ptpn6, which inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation and limits IL-1α release, and TRPM2 channels, which modulate cytokine production in lung interstitial macrophages.
• Dysregulated IL-1α production is linked to inflammatory skin diseases such as acne and psoriasis, to cancer progression and metastasis, and to host defense against intracellular pathogens such as Brucella abortus.
• Genetic variation in the IL1A gene, including an intronic polymorphic repeat, can modulate IL-1α gene regulation and may influence disease susceptibility.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of negative regulatory circuits controlling IL-1α production.
Description
Interleukin-1 alpha (IL-1α) is a pleiotropic cytokine that plays a central role in inflammation, immune surveillance, and tissue homeostasis. Unlike IL-1β, IL-1α is constitutively expressed in many cell types and can act both as a nuclear factor and as a secreted alarmin. The Gene Ontology term GO:0032690, negative regulation of interleukin-1 alpha production, encompasses all processes that stop, prevent, or reduce the frequency, rate, or extent of IL-1α production, including its biosynthetic process and secretion. Understanding this regulatory node is essential because unchecked IL-1α production drives pathological inflammation in diseases ranging from acne and psoriasis to cancer. Research has identified multiple layers of negative regulation. For example, the phosphatase Ptpn6 acts as a brake on caspase-8- and Ripk3/Mlkl-dependent inflammation, thereby limiting IL-1α release and preventing excessive tissue damage. In lung interstitial macrophages, TRPM2 channels are essential for regulating cytokine production, including IL-1α, highlighting ion channel-dependent control mechanisms. Additionally, IL-1α itself can influence host defense; it restricts Brucella abortus survival by promoting lysosomal killing and nitric oxide production in macrophages. These findings underscore the importance of negative regulatory mechanisms in balancing protective immunity and immunopathology. The clinical relevance of GO:0032690 is broad. In dermatology, IL-1α is a key mediator in acne pathogenesis, where diet-induced metabolic changes can trigger inflammation and comedogenesis, and it is elevated in psoriatic lesions. In oncology, intracellular IL-1α in peritumoral monocytes induces IL-8 production and inhibits mitophagy to promote stemness and metastasis in hepatocellular carcinoma. Genetic studies have shown that an intronic polymorphic repeat sequence in the IL1A gene modulates its regulation, providing a mechanistic link to inter-individual differences in inflammatory responses. Thus, deciphering the negative regulation of IL-1α production offers opportunities for therapeutic intervention across inflammatory and malignant diseases.
negative regulation of interleukin-1 alpha production At A Glance
| GO ID | GO:0032690 |
|---|---|
| GO term | negative regulation of interleukin-1 alpha production |
| Ontology | biological_process |
| Synonym | down regulation of interleukin-1 alpha production; down-regulation of interleukin-1 alpha production; downregulation of interleukin-1 alpha production; inhibition of interleukin-1 alpha production; negative regulation of IL-1 alpha production; negative regulation of interleukin-1 alpha biosynthetic process; negative regulation of interleukin-1 alpha secretion |
| Major function | Suppression of the frequency, rate, or extent of IL-1α production, including biosynthesis and secretion |
| Related cytokine | Interleukin-1 alpha (IL-1α), a dual-function alarmin and nuclear factor |
| Key negative regulators | Ptpn6, TRPM2, and other modulators of caspase-8/Ripk3/Mlkl signaling |
| Associated diseases | Acne, psoriasis, hepatocellular carcinoma, and bacterial infections |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, cytokine assays |
What Is GO:0032690?
GO:0032690, negative regulation of interleukin-1 alpha production, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production. This includes negative regulation of IL-1α biosynthetic process and negative regulation of IL-1α secretion. The term is a biological process and is used to annotate gene products that act as brakes on the generation or release of this cytokine.
Why Is negative regulation of interleukin-1 alpha production Important in Cell Biology?
Negative regulation of interleukin-1 alpha production is critical for maintaining immune homeostasis and preventing inflammatory pathology. IL-1α is a potent alarmin that, when overproduced, contributes to chronic inflammation, tissue damage, and tumor progression. Elucidating the molecular brakes on IL-1α production provides insight into disease mechanisms and identifies potential therapeutic targets for inflammatory skin diseases, cancer, and infectious diseases.
• Prevents excessive inflammation by limiting IL-1α release from damaged or activated cells.
• Modulates host defense against intracellular pathogens such as Brucella abortus.
• Dysregulation is implicated in acne pathogenesis and comedogenesis.
• Elevated IL-1α is observed in psoriatic lesions, linking negative regulation to psoriasis.
• Intracellular IL-1α in peritumoral monocytes promotes stemness and metastasis in hepatocellular carcinoma.
• Ptpn6-dependent inhibition of caspase-8/Ripk3/Mlkl signaling restricts IL-1α-driven inflammation.
• TRPM2 channels regulate cytokine production in lung interstitial macrophages, affecting IL-1α.
• Genetic polymorphisms in IL1A can alter gene regulation and influence disease susceptibility.
• IL-1α can induce GM-CSF in bone marrow cells, so its negative regulation impacts hematopoiesis.
• Targeting negative regulatory pathways may offer new therapeutic strategies for inflammatory diseases.
What Happens During negative regulation of interleukin-1 alpha production?
Inhibition of IL-1α biosynthesis
In simple terms: The cell reduces the amount of new IL-1α protein being made.
Negative regulation of IL-1α production can occur at the transcriptional or post-transcriptional level, reducing the synthesis of the IL-1α precursor. For example, an intronic polymorphic repeat sequence in the IL1A gene modulates its regulation, affecting the rate of IL-1α gene expression. This step ensures that less IL-1α protein is available for subsequent processing and release.
Suppression of inflammasome-dependent and independent release
In simple terms: The cell blocks the pathways that would normally let IL-1α out.
IL-1α can be released through caspase-8- and Ripk3/Mlkl-dependent inflammatory cell death pathways. Ptpn6 acts as a negative regulator of these pathways, thereby inhibiting IL-1α release and limiting inflammation. This mechanism is crucial for preventing uncontrolled cytokine storm and tissue damage.
Ion channel-mediated modulation
In simple terms: Specialized channels in the cell membrane can turn down cytokine production.
TRPM2 channels are essential for regulation of cytokine production in lung interstitial macrophages, including IL-1α. Their activity can influence the frequency and extent of IL-1α production, representing a calcium-dependent negative regulatory mechanism.
Feedback control by IL-1α itself
In simple terms: IL-1α can trigger signals that eventually shut down its own production.
IL-1α can induce secondary mediators such as GM-CSF in immature normal bone marrow cells, which may feed back to modulate inflammatory responses. Although direct negative feedback on IL-1α production is not fully characterized, such loops contribute to the resolution of inflammation.
Host-pathogen interactions
In simple terms: The immune system uses IL-1α to fight infections, but must keep it in check.
IL-1α restricts Brucella abortus survival by promoting lysosomal-mediated killing and NO production in macrophages. Negative regulation ensures that this antimicrobial activity does not cause excessive tissue damage.
Key Genes Involved in GO:0032690 negative regulation of interleukin-1 alpha production
The following genes and proteins are involved in the negative regulation of interleukin-1 alpha production or in related inflammatory pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTPN6 | Inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation, limiting IL-1α release | Key negative regulator; knockout models show exacerbated inflammation |
| TRPM2 | Calcium-permeable ion channel essential for cytokine regulation in macrophages | Modulates IL-1α production; target for anti-inflammatory strategies |
| IL1A | Encodes interleukin-1 alpha; subject to negative regulation at transcriptional and post-transcriptional levels | Intronic repeat polymorphism affects gene regulation |
| CASP8 | Caspase-8 mediates inflammatory cell death and IL-1α release | Inhibited by Ptpn6; component of the regulatory axis |
| RIPK3 | Kinase involved in necroptosis and inflammatory signaling | Part of the Ptpn6-regulated pathway |
| MLKL | Executioner of necroptosis; contributes to IL-1α release | Downstream of Ripk3; regulated by Ptpn6 |
| IL1B | Interleukin-1 beta, related cytokine | Often co-regulated with IL-1α; context for inflammatory studies |
| TNF | Tumor necrosis factor alpha, pro-inflammatory cytokine | Co-regulated in psoriasis and acne |
| IFNG | Interferon gamma, pro-inflammatory cytokine | Elevated in psoriatic lesions |
| CSF2 | GM-CSF, induced by IL-1α in bone marrow cells | Links IL-1α to hematopoiesis |
| IL8 | Chemokine induced by intracellular IL-1α in tumor monocytes | Promotes stemness and metastasis in HCC |
| NOS2 | Inducible nitric oxide synthase; NO production restricts Brucella | Effector of IL-1α-mediated killing |
| NLRP3 | Inflammasome sensor that can influence IL-1 family cytokine processing | Context-dependent role in IL-1α regulation |
| GSDMD | Gasdermin D, mediator of pyroptosis and cytokine release | Potential downstream effector of IL-1α release |
| IL1R1 | IL-1 receptor type 1, mediates IL-1α signaling | Feedback regulation of inflammation |
| MYD88 | Adaptor protein in IL-1 receptor signaling | Downstream of IL-1α; modulates inflammatory output |
| NFKB1 | Transcription factor driving pro-inflammatory gene expression | Central to IL-1α-induced inflammation |
| MAPK14 | p38 MAP kinase, regulates cytokine production | Potential target for negative regulation |
How Is negative regulation of interleukin-1 alpha production Regulated?
Negative regulation of IL-1α production is controlled by multiple signaling pathways. Ptpn6 acts as a critical brake on caspase-8- and Ripk3/Mlkl-dependent inflammation, thereby limiting IL-1α release. TRPM2 channels modulate cytokine production in lung interstitial macrophages, likely through calcium-dependent signaling. Additionally, genetic elements such as an intronic polymorphic repeat in the IL1A gene can modulate its regulation. These mechanisms ensure that IL-1α production is tightly controlled to prevent excessive inflammation.
negative regulation of interleukin-1 alpha production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL1A | Acne, psoriasis | Knockout or knock-in of IL1A in keratinocytes; cytokine assays |
| PTPN6 | Inflammatory diseases | Ptpn6 knockout mice; macrophage inflammation assays |
| TRPM2 | Lung inflammation | TRPM2 knockout mice; lung interstitial macrophage cytokine profiling |
| IL1A | Hepatocellular carcinoma | Peritumoral monocyte co-culture; IL-8 and mitophagy assays |
| IL1A | Brucella abortus infection | Macrophage infection models; lysosomal killing and NO assays |
Inflammatory Skin Diseases: Acne and Psoriasis
IL-1α is a key mediator in acne pathogenesis, where diet-induced metabolic changes can trigger inflammation and comedogenesis. In psoriasis, IL-1α, TNF-α, and IFN-γ are elevated in lesions, contributing to chronic inflammation. Negative regulation of IL-1α production is therefore critical to prevent or resolve these skin conditions.
Cancer: Hepatocellular Carcinoma
Intracellular IL-1α in peritumoral monocytes induces IL-8 production and inhibits mitophagy to promote stemness and metastasis of hepatocellular carcinoma. Loss of negative regulation can enhance tumor progression, making this pathway a potential therapeutic target.
Infectious Diseases: Brucella abortus
IL-1α restricts Brucella abortus survival by promoting lysosomal-mediated killing and NO production in macrophages. Negative regulation must balance effective pathogen clearance with prevention of immunopathology.
From negative regulation of interleukin-1 alpha production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTPN6 increase IL-1α production? | PTPN6 knockout macrophages or mice |
| Does TRPM2 channel activity modulate IL-1α in lung macrophages? | TRPM2 knockout or point-mutation models |
| How does the IL1A intronic repeat affect gene regulation? | Knock-in of polymorphic repeat variants in reporter cell lines |
| Does intracellular IL-1α promote HCC metastasis? | IL1A knockout or overexpression in peritumoral monocytes |
| Can IL-1α enhance Brucella killing without excessive inflammation? | IL1A knockout macrophages; infection assays |
| What is the role of IL-1α in psoriasis? | Skin-specific IL1A overexpression or knockout mice |
How to Study the negative regulation of interleukin-1 alpha production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted IL-1α protein levels | Quantifying cytokine production in supernatants |
| Intracellular cytokine staining | IL-1α-producing cells | Flow cytometry analysis of immune cells |
| RNA-seq | IL1A mRNA expression and transcriptome changes | Identifying negative regulators and pathways |
| CRISPR knockout screening | Genes whose loss increases IL-1α production | Discovery of novel negative regulators |
| Immunoblotting | Protein levels and phosphorylation of signaling intermediates | Validating Ptpn6-caspase-8-Ripk3 axis |
| Reporter assays | Transcriptional activity of IL1A regulatory elements | Studying intronic repeat polymorphism |
| Macrophage infection assays | Brucella survival and NO production | Linking IL-1α to antimicrobial defense |
| Co-culture assays | IL-8 production and mitophagy in tumor cells | Modeling HCC microenvironment |
Cytokine Production Assays
ELISA, Luminex, or intracellular cytokine staining can quantify IL-1α levels in supernatants and cell lysates. These methods are used to assess the impact of negative regulators such as Ptpn6 or TRPM2 on IL-1α production.
CRISPR-Based Genetic Screens
Pooled CRISPR knockout or activation screens can identify novel negative regulators of IL-1α production. Candidate genes are validated by targeted knockout and cytokine profiling.
Transcriptional and Post-Transcriptional Analysis
RNA-seq, qPCR, and reporter assays measure IL1A mRNA levels and stability. The intronic polymorphic repeat in IL1A can be studied using minigene constructs.
Proteomics and Signaling Studies
Phosphoproteomics and immunoblotting can reveal signaling pathways, such as caspase-8/Ripk3/Mlkl, that are modulated by negative regulators like Ptpn6.
How CRISPR Can Be Used to Study GO:0032690 negative regulation of interleukin-1 alpha production
Knockout
CRISPR knockout of negative regulators such as PTPN6 or TRPM2 can reveal their role in suppressing IL-1α production. For example, Ptpn6 knockout macrophages exhibit increased caspase-8- and Ripk3/Mlkl-dependent inflammation and IL-1α release.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites. For instance, mutating the catalytic site of Ptpn6 can clarify its phosphatase-dependent regulation of IL-1α.
Knock-in
Knock-in of disease-associated variants, such as the intronic polymorphic repeat in IL1A, allows study of how genetic variation affects IL-1α production. Tagged knock-in of IL1A can also enable tracking of protein localization and secretion.
Overexpression
Overexpression of negative regulators like Ptpn6 or TRPM2 can suppress IL-1α production, providing gain-of-function evidence. Conversely, overexpression of IL-1α itself can model inflammatory diseases.
How EDITGENE Supports negative regulation of interleukin-1 alpha production Research
Researchers studying negative regulation of interleukin-1 alpha production-related genes often need to determine whether a candidate gene is causally involved in suppressing IL-1α synthesis or release. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of interleukin-1 alpha production research.
Frequently Asked Questions About negative regulation of interleukin-1 alpha production
What is GO:0032690?
GO:0032690 is the Gene Ontology term for negative regulation of interleukin-1 alpha production, describing any process that stops, prevents, or reduces the frequency, rate, or extent of IL-1α production.
What genes are involved in negative regulation of interleukin-1 alpha production?
Key genes include PTPN6, which inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation, and TRPM2, which modulates cytokine production in macrophages. IL1A itself is subject to regulation by an intronic polymorphic repeat.
How is IL-1α production negatively regulated?
Negative regulation occurs at multiple levels, including transcriptional suppression, inhibition of inflammasome-dependent release, and ion channel-mediated modulation. Ptpn6 and TRPM2 are examples of negative regulators.
What diseases are associated with dysregulated IL-1α production?
Dysregulated IL-1α production is linked to acne, psoriasis, hepatocellular carcinoma, and infections such as Brucella abortus.
What is the role of PTPN6 in IL-1α regulation?
PTPN6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation, thereby limiting IL-1α release and preventing excessive inflammation.
How do TRPM2 channels affect IL-1α?
TRPM2 channels are essential for regulation of cytokine production in lung interstitial macrophages, including IL-1α.
Can CRISPR be used to study negative regulation of IL-1α production?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of regulatory mechanisms controlling IL-1α production.
What is the link between IL-1α and cancer?
Intracellular IL-1α in peritumoral monocytes induces IL-8 production and inhibits mitophagy to promote stemness and metastasis of hepatocellular carcinoma.
How does IL-1α contribute to psoriasis?
IL-1α, along with TNF-α and IFN-γ, is elevated in psoriatic lesions and contributes to chronic inflammation.
What experimental models are used to study negative regulation of IL-1α production?
Common models include knockout mice or cells for PTPN6 and TRPM2, knock-in of IL1A variants, and overexpression systems, combined with cytokine assays and RNA-seq.
Conclusion
GO:0032690, negative regulation of interleukin-1 alpha production, represents a critical control point in inflammatory and immune responses. Dysregulation of this process contributes to skin diseases, cancer, and infectious pathology. Continued research using CRISPR-based models and advanced omics will further elucidate the molecular brakes on IL-1α production, offering new avenues for therapeutic intervention.
References
- 1. Melnik BC. 2015. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.. Clin Cosmet Investig Dermatol 8:371-88 PMID: 26203267
- 2. Speir M et al.. 2020. Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation.. Nat Immunol 21(1):54-64 PMID: 31819256
- 3. Ruan YH et al.. 2025. Intracellular IL1α in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma.. Cancer Res 85(21):4164-4181 PMID: 40857615
- 4. Rajan S et al.. 2024. TRPM2 channels are essential for regulation of cytokine production in lung interstitial macrophages.. J Cell Physiol 239(11):e31322 PMID: 38785126
- 5. Hop HT et al.. 2019. Interleukin 1 alpha (IL-1α) restricts Brucella abortus 544 survival through promoting lysosomal-mediated killing and NO production in macrophages.. Vet Microbiol 232:128-136 PMID: 31030836
- 6. Gomi T et al.. 1991. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.. Arch Dermatol 127(6):827-30 PMID: 1903629
- 7. Bailly S et al.. 1996. An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation.. Mol Immunol 33(11-12):999-1006 PMID: 8960124
- 8. Bot FJ et al.. 1990. Interleukin-1 alpha also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells.. Blood 76(2):307-11 PMID: 1695108
